FDA OKs Nitisinone for Ultra-Rare Black Urine Disease

(MedPage Today) — The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in adults with alkaptonuria, Cycle Pharmaceuticals announced on Thursday.
Alkaptonuria is an ultra-rare hereditary disorder of tyrosine…